MAXITROL® OPHTHALMIC SUSPENSION


Ophthalmic Suspension
scheduling status
S4
registration number
H1145
What MAXITROL® OPHTHALMIC SUSPENSION contains
Polymyxin B sulphate equal to 6000 international units polymyxin B base, neomycin sulphate equal to 3500 international units neomycin base and dexamethasone 1,0 mg.
other ingredients
Polysorbate 20, Sodium chloride, Hydrochloric acid, and/or Sodium hydroxide, Hydroxypropylmethylcellulose, Benzalkonium chloride, Purified water.
Therapeutic classification
S01CA01 Ophthalmologicals; Anti-infectives.
© 2026 SAHPRA. ALL RIGHTS RESERVED